Sinocare Links Home, Pharmacy and Hospital Monitoring
Edited by Mursal Rahman — October 1, 2026 — Business
This article was written with the assistance of AI.
References: prnewswire
Sinocare is developing a connected approach to chronic disease management that spans home, community pharmacy, and hospital settings. Its portfolio includes five-second Bluetooth-enabled glucose monitoring, a three-in-one glucose, uric acid, and ketone meter, and the iCARE-1300 analyzer, which tests nearly 100 parameters in pharmacies. For hospitals, AGEscan provides non-invasive risk screening, while the Safe AQ 8000 connects glucose meter and continuous glucose monitoring data with hospital information systems for centralized patient monitoring.
Bringing these tools together creates a more continuous pathway from early screening to everyday monitoring and clinical management. For healthcare providers, connected testing and patient data can support more coordinated chronic care across different environments. For Sinocare, the ecosystem expands its role beyond individual glucose meters, creating opportunities to serve consumers, pharmacies, and hospitals while strengthening demand across multiple points of the patient journey.
Image Credit: Sinocare
Bringing these tools together creates a more continuous pathway from early screening to everyday monitoring and clinical management. For healthcare providers, connected testing and patient data can support more coordinated chronic care across different environments. For Sinocare, the ecosystem expands its role beyond individual glucose meters, creating opportunities to serve consumers, pharmacies, and hospitals while strengthening demand across multiple points of the patient journey.
Image Credit: Sinocare
Trend Themes
-
Connected Chronic Care — Integrated monitoring ecosystems are reshaping disease management by linking home devices, pharmacies, and hospitals into continuous care pathways.
-
Pharmacy-based Diagnostics — Community pharmacies are emerging as accessible testing hubs where expanded analyzers can support earlier detection and more convenient follow-up.
-
Multi-parameter Monitoring — Devices that combine glucose, uric acid, ketone, and broader biomarker testing create new value by consolidating chronic risk insights into fewer touchpoints.
Industry Implications
-
Digital Health — Interoperable platforms that connect patient-generated data with clinical systems are broadening the scope of remote monitoring and centralized care.
-
Medical Devices — Bluetooth-enabled meters, continuous glucose monitors, and non-invasive screening tools are driving differentiation through connected functionality and faster diagnostics.
-
Retail Pharmacy — In-store diagnostic services supported by advanced analyzers position pharmacies as important nodes in chronic disease screening and care coordination.
4.6
Score
Popularity
Activity
Freshness
